Lupus & antiphospholipid syndrome

Declining Incidence of Systemic Lupus Erythematosus in Norway 1999–2017: Data From a Population Cohort Identified by International Classification of Diseases, 10th Revision Code and Verified by Classification

Arthritis RheumatolPublished Population-based cohort study

Authors' conclusion

In a presumably complete population-based cohort, we identified decreasing incidence of SLE, especially among female persons 50 to 59 years old.

Study context

Population
All cases ICD-10 coded as systemic lupus erythematosus (SLE) in Southeast Norway (2.9 million inhabitants), 1999 through 2017797 new-onset SLE
Participants
3,488 participants
Outcome
Annual incidence rates of classified SLE, and subsets by age at diagnosis, sex and parental country of birth
Methodological detailsICD-10 coded cases verified by chart review and classification criteria, chi-square test for linear time trend
  • ICD-10 coded cases verified by chart review and classification criteria
  • Chi-square test for linear time trend

Main finding

As reported in the abstract

Annual SLE incidence, 1999 to 2017
Incidence in females 50 to 59 years old at diagnosis fell from 3.4 to 1.1 per 100,000 persons
P trend < 0.001

Observational data: associations, not effects.

Further findings

Chart-confirmed SLE among ICD-10 coded cases

Confirmed SLE diagnosis
1,558 (45%)

Accuracy of ICD-10 codes for incident SLE diagnosis

Acceptable in juveniles and young adults (up to 20 years) but otherwise low

Prescriptions of menopausal hormone treatment (ecological data)

Reduction
74%

Original publication

Declining Incidence of Systemic Lupus Erythematosus in Norway 1999–2017: Data From a Population Cohort Identified by International Classification of Diseases, 10th Revision Code and Verified by Classification. Arthritis Rheumatol. Published 21 February 2024. doi:10.1002/art.42775

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.